INBX vs LHX · rev $1.3M vs P/E 34, rev $5.88B
Inhibrx Biosciences, Inc. (INBX) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
INBX currently screens at market cap $1.28B. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the INBX and LHX stock pages for the full models.
Not investment advice.